Bimatoprost Therapeutic Cheat Sheet
Bimatoprost is a prostaglandin analog originally developed for glaucoma that has become an important tool in dermatology for the treatment of eyelash and eyebrow hypotrichosis. By prolonging the anagen phase of hair growth, bimatoprost enhances lash length, thickness, and pigmentation. We continue our Therapeutic Cheat Sheet series with a closer look at bimatoprost.
Bimatoprost Therapeutic Cheat …
Bimatoprost is a prostaglandin analog originally developed for glaucoma that has become an important tool in dermatology for the treatment of eyelash and eyebrow hypotrichosis. By prolonging the anagen phase of hair growth, bimatoprost enhances lash length, thickness, and pigmentation. We continue our Therapeutic Cheat Sheet series with a closer look at bimatoprost.
Bimatoprost Therapeutic Cheat … 
Tacrolimus and Pimecrolimus are both calcineurin inhibitors FDA-approved for atopic dermatitis. However, their topical use offers steroid-sparing benefits for a wide variety of other inflammatory dermatologic conditions. Tacrolimus was discovered in 1984 from the soil bacterium Streptomyces tsukubaensis and was originally FDA approved in 1994 as a systemic immunosuppressant for organ transplanta … 
Sulfur–sulfacetamide is a long-standing topical therapy in dermatology valued for its combined antimicrobial, anti-inflammatory, and keratolytic effects. It is commonly used for several conditions including acne vulgaris, papulopustular rosacea, and seborrheic dermatitis. Although newer targeted therapies are often preferred for rosacea, sulfur–sulfacetamide remains a practical option, especia … 
Psoriasis is one of the most common immune-mediated inflammatory dermatoses, with increasing evidence for systemic comorbidities. Targeted systemic agents have revolutionized the management of moderate-to-severe psoriasis, with life-changing outcomes for many patients with the chronic disease. Injectable biologics, blocking interleukin (IL)-23 or IL-17 cytokine pathways, have become invaluable opt … 
Sarecycline is a third-generation, narrow-spectrum tetracycline developed specifically for the treatment of acne vulgaris. It is distinguished by its weight-based once-daily dosing, favorable side effect profile, and relative microbiome-sparing compared with older tetracyclines. We continue our series, Therapeutic Cheat Sheet, with a closer look at Sarecycline.
� …